Who founded Endomedix?

Endomedix was founded by Piyush M..

Who are Endomedix's investors?

Endomedix's investors include Central Texas Angel Network, Houston Angel Network, Keiretsu Forum, Golden Seeds.

How much funding has Endomedix raised?

Endomedix has disclosed $1.2M raised across 1 round.

Where is Endomedix headquartered?

Endomedix is headquartered in Montclair, US.

Endomedix

Montclair, US · 4 known investors

Find your way into Endomedix

Your email: who you already know at Endomedix, and who your contacts know
2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Endomedix team
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Endomedix is developing PLEXimine, a technology platform based on polysaccharide chemistry that lets surgeons form structured medical devices in situ during procedures. The company focuses on biosurgery and related medical applications.

Biotech Healthtech Medical Devices New Materials

Founders & leadership

Piyush M.FounderPiyush M. is founder of Endomedix and lead inventor of a polysaccharide-based platform technology for biosurgical devices. He has expertise in biomaterials science, materials characterization, and machine learning applied to biopolymer processing, with prior experience in military and government programs.

Weiliam ChenNamed on SEC filing

James R. PastenaNamed on SEC filing

John M. AbrahamsNamed on SEC filing

Richard RussoNamed on SEC filing

Richard OlsonNamed on SEC filing

Investors · 4

Central Texas Angel Networklisted by Central Texas Angel NetworkAustin

How we know: Central Texas Angel Network's portfolio page · Not right? Tell us

Houston Angel Networklisted by Houston Angel NetworkHouston

Keiretsu Forumlisted by Keiretsu ForumSan Francisco East Bay · $250K – $2M

How we know: Keiretsu Forum's portfolio page · Not right? Tell us

Golden SeedsreportedFlushing · $250K – $2M

How we know: funding news · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$1.2M disclosed across 1 round · 2019

▶$1.2MraisedMay 2019 · 9 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Weiliam ChenDirector
James R. PastenaDirector
John M. AbrahamsDirector
Richard RussoExecutive Officer, Director
Richard OlsonDirector

Offering amount: $2.5M
Amount sold: $1.2M
First sale: May 2019
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Endomedix do?: Endomedix is developing PLEXimine, a technology platform based on polysaccharide chemistry that lets surgeons form structured medical devices in situ during procedures. The company focuses on biosurgery and related medical applications.
Who founded Endomedix?: Endomedix was founded by Piyush M..
Who are Endomedix's investors?: Endomedix's investors include Central Texas Angel Network, Houston Angel Network, Keiretsu Forum, Golden Seeds.
How much funding has Endomedix raised?: Endomedix has disclosed $1.2M raised across 1 round.
Where is Endomedix headquartered?: Endomedix is headquartered in Montclair, US.